220 reports of this reaction
1.4% of all ERTAPENEM SODIUM reports
#18 most reported adverse reaction
PARAESTHESIA ORAL is the #18 most commonly reported adverse reaction for ERTAPENEM SODIUM. There are 220 FDA adverse event reports linking ERTAPENEM SODIUM to PARAESTHESIA ORAL. This represents approximately 1.4% of all 15,826 adverse event reports for this drug.
Patients taking ERTAPENEM SODIUM who experience paraesthesia oral should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PARAESTHESIA ORAL is a less commonly reported adverse event for ERTAPENEM SODIUM, but still significant enough to appear in the safety profile.
In addition to paraesthesia oral, the following adverse reactions have been reported for ERTAPENEM SODIUM:
The following drugs have also been linked to paraesthesia oral in FDA adverse event reports:
PARAESTHESIA ORAL has been reported as an adverse event in 220 FDA reports for ERTAPENEM SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
PARAESTHESIA ORAL accounts for approximately 1.4% of all adverse event reports for ERTAPENEM SODIUM, making it a notable side effect.
If you experience paraesthesia oral while taking ERTAPENEM SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.